Tag: anti-SARS-CoV-2 plasma product
CSL Behring Australia Commences Development of Treatment for Serious Cases of COVID-19
Media Release
CSL Behring Australia, a subsidiary of CSL Limited, today announced that it will begin immediate onshore development of an anti-SARS-CoV-2 plasma product with...
Featured Article
Xometry CEO Sanjeev Singh Sahni on how AI and digital networks are reshaping manufacturing supply chains
Australian manufacturers have long competed against distance. In an exclusive interview with Australian Manufacturing, Xometry CEO Sanjeev Singh Sahni discusses how AI can help manufacturers access more production capacity and simplify traditionally email-driven supply chains.
